Back
Cardiff Oncology, Inc. Stock Price Chart
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
29
CRDF
Cardiff Oncology, Inc.
Last Price:
$2.91
Seasonality Move:
-2.87%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing selling pressure, which indicates risk of future bearish movement.
Cardiff Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.87 | Buy |
| 20-day SMA: | 2.95 | Sell |
| 50-day SMA: | 2.52 | Buy |
| 200-day SMA: | 2.72 | Buy |
| 8-day EMA: | 2.9 | Buy |
| 20-day EMA: | 2.84 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 1.71 | Buy |
Cardiff Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 54.28 | Buy |
| Chaikin Money Flow: | -312684 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.62 - 3.08) | Buy |
| Bollinger Bands (100): | (2.01 - 2.67) | Buy |
Cardiff Oncology, Inc. Technical Analysis
| Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cardiff Oncology, Inc. Stock
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 2.90 while CRDF 8-day simple moving average is 2.87, which is a Buy signal.
-
The stock price of CRDF is 2.90 while Cardiff Oncology, Inc. 20-day SMA is 2.95, which makes it a Sell.
-
Cardiff Oncology, Inc. 50-day simple moving average is 2.52 while CRDF share price is 2.90, making it a Buy technically.
-
CRDF stock price is 2.90 and Cardiff Oncology, Inc. 200-day simple moving average is 2.72, creating a Buy signal.
CRDF Technical Analysis vs Fundamental Analysis
Sell
29
Cardiff Oncology, Inc. (CRDF)
is a Sell
Is Cardiff Oncology, Inc. a Buy or a Sell?
-
Cardiff Oncology, Inc. stock is rated a SellThe current Cardiff Oncology, Inc. [CRDF] share price is $2.90. The Score for CRDF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Cardiff Oncology, Inc. Stock Info
Market Cap:
195.3M
Price in USD:
2.90
Share Volume:
408.9K
Cardiff Oncology, Inc. 52-Week Range
52-Week High:
4.99
52-Week Low:
1.90
Sell
29
Cardiff Oncology, Inc. (CRDF)
is a Sell
Cardiff Oncology, Inc. Share Price Forecast
-
What is the Cardiff Oncology, Inc. stock price today?The Cardiff Oncology, Inc. stock price is 2.90 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology, Inc. is overvalued.
Is Cardiff Oncology, Inc. Stock a Buy?
-
Cardiff Oncology, Inc. share price is 2.90 while CRDF 8-day exponential moving average is 2.90, which is a Buy signal.
-
The stock price of CRDF is 2.90 while Cardiff Oncology, Inc. 20-day EMA is 2.84, which makes it a Buy.
-
Cardiff Oncology, Inc. 50-day exponential moving average is 2.62 while CRDF share price is 2.90, making it a Buy technically.
-
CRDF stock price is 2.90 and Cardiff Oncology, Inc. 200-day simple moving average is 1.71, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology, Inc.
Is Cardiff Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Cardiff Oncology, Inc.
Should I short Cardiff Oncology, Inc. stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Cardiff Oncology, Inc. is a Buy
-
Cardiff Oncology, Inc. Relative Strength Index (RSI) is 54.28, which suggest Cardiff Oncology, Inc. is overbought
-
The Bollinger Bands (25) for Cardiff Oncology, Inc. is (2.62 - 3.08), which suggest Cardiff Oncology, Inc. is a Buy
-
The Bollinger Bands (100) for Cardiff Oncology, Inc. is (2.01 - 2.67), which suggest Cardiff Oncology, Inc. is a Buy
* Cardiff Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.